 |
 |
initiation, speed, tremor, and tone. This clinical trial will be limited to patients who experience disruptive slowness of movement or difficulty initiating movements (also known as "freezing" or start hesitation). In addition, participants must be over age 20 (male or female), have a diagnosis of mild to moderately severe PD (Hoehn and Yahr stage II-IV), be on a stable regimen of antiparkinsonian medications, and not experience disabling memory impairment. Subjects with a pacemaker or brain-stimulating device are not eligible for the study. The study will take place at Johns Hopkins Hospital and will require about 4 hours of testing. The testing can take place over two separate days. Participants will be provided free parking and compensated $20 for their time and the costs of traveling to Johns Hopkins. If you are interested in participating, please contact Melissa Gerstenhaber, R.N., M.S.N., Research Nurse Coordinator for the Morris K. Udall Parkinson's Disease Research Center of Excellence at Johns Hopkins (410-614-1242) or email her at [log in to unmask] The principal investigator of this study is Laura Marsh, M.D.. Lockheed Martin Corporation and the National Institutes of Health are providing financial support for the study. ************************************************************* Note: If you are interested in participating in the study or have questions related to participation, contact Melissa. Otherwise, please do not contact her with technical questions about the device works. You can address technical questions to me. Phil Gesotti 53/dx46 ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn